Taro to Announce Full Year Results on May 17, 2018
May 11 2018 - 3:00PM
Business Wire
Earnings Call to Discuss Results to be
Conducted Friday, May 18 at 8:00 am EDT
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today
that it plans to release its financial results for year ended March
31, 2018, on Thursday, May 17, 2018.
The Company will conduct an earnings call at 8:00 am EDT on
Friday, May 18, 2018, where senior management will discuss the
Company’s performance and answer questions from participants.
The release will be accessible on Taro’s website at
www.taro.com.
Earnings Call (8:00 am EDT
on Friday, May 18, 2018)
To participate in this conference call, please dial the numbers
provided below five to ten minutes ahead of the scheduled start
time. The operator will provide instructions on asking questions
before the call. You can also hear the call via an audio webcast,
details of which will be announced later on the Company website,
www.taro.com. A transcript of this
earnings call will also be available on the website.
Summary of events
Event Date and time
Telephone number / website
Earnings release May 17, 2018 (AMC)
www.taro.com
Earnings conference call
May 18, 2018
Participant Toll-Free Dial-In Number: +1
(844) 421-0601
8:00 am EDT
Participant International Dial-In Number:
+1 (716) 247-5800
ID: 3249428
Via audio webcast, details of which will
be made available on www.taro.com
Replay of conference call
May 18, 2018 to
+ 1 (855) 859-2056 or +1 (404)
537-3406
May 31, 2018
ID: 3249428
Via audio webcast playback, details of
which will be made available on www.taro.com
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational,
science-based pharmaceutical company, dedicated to meeting the
needs of its customers through the discovery, development,
manufacturing and marketing of the highest quality healthcare
products. For further information on Taro Pharmaceutical Industries
Ltd., please visit the Company’s website at www.taro.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180511005525/en/
Taro Pharmaceutical Industries Ltd.Mariano A. Balaguer,
914-345-9001VP, CFOMariano.Balaguer@taro.comorWilliam J. Coote,
914-345-9001AVP, Business Finance, Treasurer and Investor
RelationsWilliam.Coote@taro.com
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Apr 2023 to Apr 2024